{"id":66350,"date":"2026-01-17T08:52:02","date_gmt":"2026-01-17T07:52:02","guid":{"rendered":"https:\/\/www.parkinson-hotline.com\/?p=66350"},"modified":"2026-02-03T04:23:04","modified_gmt":"2026-02-03T03:23:04","slug":"vai-slimibas-gaitu-var-paleninat","status":"publish","type":"post","link":"https:\/\/www.parkinson-hotline.com\/lv\/kann-man-den-verlauf-der-erkrankung-verlangsamen\/","title":{"rendered":"Vai slim\u012bbas progres\u0113\u0161anu var pal\u0113nin\u0101t?"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Vai slim\u012bbas progres\u0113\u0161anu var pal\u0113nin\u0101t?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t


Ievads<\/strong><\/p>

Viens no bie\u017e\u0101k uzdotajiem jaut\u0101jumiem cilv\u0113kiem ar Parkinsona slim\u012bbu un vi\u0146u tuviniekiem ir:\u201eVai slim\u012bbas progres\u0113\u0161anu var pal\u0113nin\u0101t?\u201c<\/strong><\/p>

Pa\u0161laik Parkinsona slim\u012bba nav \u0101rst\u0113jama. Tom\u0113r medic\u012bnas atkl\u0101jumi liecina, ka da\u017eas terapeitisk\u0101s pieejas var funkcion\u0101l\u0101 att\u012bst\u012bba<\/strong> var pozit\u012bvi ietekm\u0113t slim\u012bbu.<\/p>

\u0160aj\u0101 proces\u0101 M\u0113r\u0137tiec\u012bgas kust\u012bbas, motorikas m\u0101c\u012b\u0161an\u0101s un individu\u0101li piel\u0101gotas m\u0101c\u012bbas<\/strong> tiem ir galven\u0101 noz\u012bme, jo tos izmanto ar\u012b specializ\u0113tajos terapijas veidos, piem\u0113ram, GIGER\u00ae MD\u00ae terapij\u0101.<\/p>

\u00a0<\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Ko paties\u012bb\u0101 noz\u012bm\u0113 \u201epal\u0113nin\u0101t progresu\u201c?<\/strong><\/p>

Kad m\u0113s run\u0101jam par Parkinsona slim\u012bbas progres\u0113\u0161anu, m\u0113s nerun\u0101jam par pa\u0161as slim\u012bbas aptur\u0113\u0161anu, bet gan par:<\/p>

  • p\u0113c iesp\u0113jas ilg\u0101k saglab\u0101t mobilit\u0101ti,<\/li>
  • funkcion\u0101lo ierobe\u017eojumu kav\u0113\u0161an\u0101s,<\/li>
  • liel\u0101ku dro\u0161\u012bbu un neatkar\u012bbu ikdienas dz\u012bv\u0113.<\/li><\/ul>


    Slim\u012bbas gaita ir \u013coti at\u0161\u0137ir\u012bga da\u017e\u0101diem cilv\u0113kiem. Iz\u0161\u0137iro\u0161ais faktors ir tas, cik agri un cik m\u0113r\u0137tiec\u012bgi tiek \u012bstenoti atbalsta pas\u0101kumi.<\/p>


    K\u0101di faktori ietekm\u0113 Parkinsona slim\u012bbas norisi?<\/strong><\/p>

    Parkinsona slim\u012bbas gaitu ietekm\u0113 t\u0101di faktori k\u0101.<\/p>

    • slim\u012bbas s\u0101kums un veids,<\/li>
    • \u0123en\u0113tiskie un biolo\u0123iskie faktori,<\/li>
    • z\u0101\u013cu terapija,<\/li>
    • aktivit\u0101tes l\u012bmenis un uzved\u012bba.

      <\/li><\/ul>

      Lai gan biolo\u0123iskos faktorus nevar ietekm\u0113t, m\u0113r\u0137tiec\u012bga vingrojumu terapija var sniegt b\u016btisku ieguld\u012bjumu.<\/p>

      \u00a0
      K\u0101da noz\u012bme ir kust\u012bbai?<\/strong><\/p>

      Tagad fizisk\u0101s aktivit\u0101tes ir atz\u012btas par b\u016btisku Parkinsona slim\u012bbas \u0101rst\u0113\u0161anas sast\u0101vda\u013cu. P\u0113t\u012bjumi liecina, ka regul\u0101ras, struktur\u0113tas fizisk\u0101s aktivit\u0101tes:<\/p>

      • ilg\u0101ku mobilit\u0101ti,<\/li>
      • Stabiliz\u0113jas ikdienas funkcijas,<\/li>
      • var samazin\u0101t kritiena risku.

        <\/li><\/ul>

        Ne visas kust\u012bbas ir vienl\u012bdz efekt\u012bvas. Iz\u0161\u0137iro\u0161ais faktors ir tas, vai kust\u012bba M\u0113r\u0137tiec\u012bga, apzin\u0101ta un uz m\u0101c\u012b\u0161anos orient\u0113ta<\/strong> tiek izmantots.<\/p>


        K\u0101p\u0113c m\u0113r\u0137tiec\u012bga apm\u0101c\u012bba ir svar\u012bg\u0101ka par t\u012bru aktivit\u0101ti<\/strong><\/p>

        Pastaigas vai visp\u0101r\u0113jas aktivit\u0101tes ir noder\u012bgas, ta\u010du bie\u017ei vien ar t\u0101m nepietiek, lai pan\u0101ktu ilgsto\u0161us funkcion\u0101lus uzlabojumus.
        T\u0101p\u0113c modern\u0101s terapeitisk\u0101s pieejas, piem\u0113ram, GIGER\u00ae MD\u00ae terapija, ir balst\u012btas uz:<\/p>

        • akt\u012bvas, apzin\u0101ti kontrol\u0113tas kust\u012bbu sekvences,<\/li>
        • sare\u017e\u0123\u012btas koordin\u0101cijas un l\u012bdzsvara pras\u012bbas,<\/li>
        • ritmiskas un struktur\u0113tas kust\u012bbu sh\u0113mas,<\/li>
        • individu\u0101li piel\u0101goti m\u0101c\u012bbu stimuli.<\/li>
        • \u00a0<\/li><\/ul>

          M\u0113r\u0137is ir \u012bpa\u0161i izaicin\u0101t nervu sist\u0113mu un p\u0113c iesp\u0113jas ilg\u0101k stabiliz\u0113t funkcion\u0101l\u0101s sp\u0113jas.
          \u00a0<\/p>

          Saikne ar neiroplasticit\u0101ti<\/p>

          Pat ar Parkinsona slim\u012bbu smadzenes joproj\u0101m sp\u0113j m\u0101c\u012bties. \u0160o piel\u0101go\u0161an\u0101s sp\u0113ju sauc par neiroplasticit\u0101ti.
          Terapijas veidi, piem\u0113ram, GIGER\u00ae MD\u00ae terapija, izmanto \u0161o principu:
          vienlaic\u012bgi piev\u0113rsties vair\u0101k\u0101m ma\u0146u un kust\u012bbu sist\u0113m\u0101m,
          apvienot koordin\u0113tas un ritmiskas kust\u012bbas,
          akt\u012bvi veicin\u0101t motorisko m\u0101c\u012b\u0161anos.
          Neiroplasticit\u0101te nenoz\u012bm\u0113 iz\u0101rst\u0113\u0161anu, bet gan lab\u0101ku eso\u0161o neironu resursu izmanto\u0161anu.<\/p>

          \u00a0
          Kur ir robe\u017eas?<\/strong><\/p>

          Lai cik svar\u012bga b\u016btu m\u0113r\u0137tiec\u012bga vingrojumu terapija, t\u0101 nevar aizst\u0101t \u0101rst\u0113\u0161anu.Parkinsona slim\u012bba joproj\u0101m ir progres\u0113jo\u0161a neirolo\u0123iska slim\u012bba.
          T\u0101p\u0113c m\u0113r\u0137is ir nevis iz\u0101rst\u0113t, bet gan<\/p>

          • pal\u0113nin\u0101t funkcion\u0101lo degrad\u0101ciju,<\/li>
          • dz\u012bves kvalit\u0101ti p\u0113c iesp\u0113jas ilg\u0101k,<\/li>
          • veicin\u0101t dro\u0161\u012bbu un neatkar\u012bbu ikdienas dz\u012bv\u0113.<\/li><\/ul>

            T\u0101das terapijas metodes k\u0101 GIGER\u00ae MD\u00ae terapija j\u0101uzskata par papildu, atbalsta pas\u0101kumu.<\/p>

            \u00a0
            Secin\u0101jums<\/strong><\/p>

            Parkinsona slim\u012bbu nav iesp\u0113jams iz\u0101rst\u0113t. Tom\u0113r slim\u012bbas skartie cilv\u0113ki var akt\u012bvi pal\u012bdz\u0113t pozit\u012bvi ietekm\u0113t slim\u012bbas funkcion\u0101lo gaitu.
            Regul\u0101ra, m\u0113r\u0137tiec\u012bga fizisk\u0101 slodze - \u012bpa\u0161i struktur\u0113t\u0101s terapijas veid\u0101, piem\u0113ram, GIGER\u00ae MD\u00ae terapij\u0101 - var pal\u012bdz\u0113t ilg\u0101k saglab\u0101t mobilit\u0101ti, koordin\u0101ciju un ikdienas dro\u0161\u012bbu.
            \u00a0<\/p>


            Autors: Combo AG, GIGER\u00ae MD\u00ae Therapy ra\u017eot\u0101js un izplat\u012bt\u0101js
            <\/strong>Medic\u012bniska piez\u012bme: \u0160is raksts ir tikai informat\u012bvs un neaizst\u0101j medic\u012bnisku padomu vai \u0101rst\u0113\u0161anu.P\u0113d\u0113jais atjaunin\u0101jums: 2026<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

            Kann man den Verlauf der Erkrankung verlangsamen? Einleitung Eine der h\u00e4ufigsten Fragen von Menschen mit Parkinson und ihren Angeh\u00f6rigen lautet:\u2028\u201eKann man den Verlauf der Erkrankung verlangsamen?\u201c Parkinson ist derzeit nicht heilbar. Dennoch zeigen medizinische Erkenntnisse, dass bestimmte therapeutische Ans\u00e4tze den funktionellen Verlauf der Erkrankung positiv beeinflussen k\u00f6nnen. Dabei spielen gezielte Bewegung, motorisches Lernen und individuell […]<\/p>\n","protected":false},"author":1,"featured_media":66354,"comment_status":"closed","ping_status":"open","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[7353,7352],"tags":[],"class_list":["post-66350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-parkinson"],"_links":{"self":[{"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/posts\/66350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/comments?post=66350"}],"version-history":[{"count":17,"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/posts\/66350\/revisions"}],"predecessor-version":[{"id":66685,"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/posts\/66350\/revisions\/66685"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/media\/66354"}],"wp:attachment":[{"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/media?parent=66350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/categories?post=66350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/tags?post=66350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}